Show simple item record

dc.contributor.authorDalvie, Neil C.
dc.contributor.authorLorgeree, Timothy R.
dc.contributor.authorYang, Yuchen
dc.contributor.authorRodriguez-Aponte, Sergio A.
dc.contributor.authorWhittaker, Charles A.
dc.contributor.authorHinckley, Joshua A.
dc.contributor.authorClark, John J.
dc.contributor.authorDel Rosario, Amanda M.
dc.contributor.authorLove, Kerry R.
dc.contributor.authorLove, J. C.
dc.date.accessioned2024-08-06T17:12:37Z
dc.date.available2024-08-06T17:12:37Z
dc.date.issued2024-07-31
dc.identifier.urihttps://hdl.handle.net/1721.1/155951
dc.description.abstractBackground The yeast Komagataella phaffii is widely used for manufacturing recombinant proteins, but secreted titers of recombinant proteins could be improved by genetic engineering. In this study, we hypothesized that cellular resources could be redirected from production of endogenous proteins to production of recombinant proteins by deleting unneeded endogenous proteins. In non-model microorganisms such as K. phaffii, however, genetic engineering is limited by lack gene annotation and knowledge of gene essentiality. Results We identified a set of endogenous secreted proteins in K. phaffii by mass spectrometry and signal peptide prediction. Our efforts to disrupt these genes were hindered by limited annotation of essential genes. To predict essential genes, therefore, we designed, transformed, and sequenced a pooled library of guide RNAs for CRISPR-Cas9-mediated knockout of all endogenous secreted proteins. We then used predicted gene essentiality to guide iterative disruptions of up to 11 non-essential genes. Engineered strains exhibited a ~20× increase in the production of human serum albumin and a twofold increase in the production of a monoclonal antibody. Conclusions We demonstrated that disruption of as few as six genes can increase production of recombinant proteins. Further reduction of the endogenous proteome of K. phaffii may further improve strain performance. The pooled library of secretome-targeted guides for CRISPR-Cas9 and knowledge of gene essentiality reported here will facilitate future efforts to engineer K. phaffii for production of other recombinant proteins and enzymes.en_US
dc.publisherBioMed Centralen_US
dc.relation.isversionof10.1186/s12934-024-02466-2en_US
dc.rightsCreative Commons Attributionen_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_US
dc.sourceBioMed Centralen_US
dc.titleCRISPR-Cas9 knockout screen informs efficient reduction of the Komagataella phaffii secretomeen_US
dc.typeArticleen_US
dc.identifier.citationDalvie, N.C., Lorgeree, T.R., Yang, Y. et al. CRISPR-Cas9 knockout screen informs efficient reduction of the Komagataella phaffii secretome. Microb Cell Fact 23, 217 (2024).en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemical Engineering
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MIT
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineering
dc.relation.journalMicrobial Cell Factoriesen_US
dc.identifier.mitlicensePUBLISHER_CC
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2024-08-04T03:14:18Z
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dspace.date.submission2024-08-04T03:14:18Z
mit.licensePUBLISHER_CC
mit.metadata.statusAuthority Work and Publication Information Neededen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record